SEC Form 4 · accession 0001127602-18-009471

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman & CEO · Director

Period of report

Feb 28, 2018

Accepted (ET)

Mar 2, 2018 · 7:28 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 28, 2018	S	100	$107.61	D	320,540	D
Common Stock	Feb 28, 2018	S	200	$107.615	D	320,340	D
Common Stock	Feb 28, 2018	S	20	$107.64	D	320,320	D
Common Stock	Feb 28, 2018	S	200	$107.68	D	320,120	D
Common Stock	Feb 28, 2018	S	24	$107.745	D	320,096	D
Common Stock	Feb 28, 2018	S	100	$107.75	D	319,996	D
Common Stock	Feb 28, 2018	S	76	$107.755	D	319,920	D
Common Stock	Feb 28, 2018	S	200	$107.775	D	319,720	D
Common Stock	Feb 28, 2018	S	400	$107.78	D	319,320	D
Common Stock	Feb 28, 2018	S	201	$107.785	D	319,119	D
Common Stock	Feb 28, 2018	S	100	$107.79	D	319,019	D
Common Stock	Feb 28, 2018	S	200	$107.795	D	318,819	D
Common Stock	Feb 28, 2018	S	100	$107.80	D	318,719	D
Common Stock	Feb 28, 2018	S	60	$107.81	D	318,659	D
Common Stock	Feb 28, 2018	S	40	$107.815	D	318,619	D
Common Stock	Feb 28, 2018	S	500	$107.82	D	318,119	D
Common Stock	Feb 28, 2018	S	600	$107.85	D	317,519	D
Common Stock	Feb 28, 2018	S	152	$107.855	D	317,367	D
Common Stock	Feb 28, 2018	S	425	$107.86	D	316,942	D
Common Stock	Feb 28, 2018	S	500	$107.865	D	316,442	D
Common Stock	Feb 28, 2018	S	120	$107.88	D	316,322	D
Common Stock	Feb 28, 2018	S	580	$107.885	D	315,742	D
Common Stock	Feb 28, 2018	S	100	$107.89	D	315,642	D
Common Stock	Feb 28, 2018	S	100	$107.905	D	315,542	D

No Table II lines on this filing.